
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Strong Balance Sheet.
Momentum: Stock price has a strong positive momentum. Stock is up 17.3% in last 30 days.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money has been increasing their position in the stock.
Past Returns: Underperforming stock! In past three years, the stock has provided -6% return compared to 10.2% by NIFTY 50.
Valuation | |
|---|---|
| Market Cap | 1.73 kCr |
| Price/Earnings (Trailing) | 26.8 |
| Price/Sales (Trailing) | 0.63 |
| EV/EBITDA | 8.23 |
| Price/Free Cashflow | 31.79 |
| MarketCap/EBT | 21.82 |
| Enterprise Value | 1.96 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 2.75 kCr |
| Rev. Growth (Yr) | 5.9% |
| Earnings (TTM) | 55.38 Cr |
| Earnings Growth (Yr) | 75.9% |
Profitability | |
|---|---|
| Operating Margin | 3% |
| EBT Margin | 3% |
| Return on Equity | 6.42% |
| Return on Assets | 2.91% |
| Free Cashflow Yield | 3.15% |
Growth & Returns | |
|---|---|
| Price Change 1W | 5.7% |
| Price Change 1M | 17.3% |
| Price Change 6M | -5.6% |
| Price Change 1Y | 0.30% |
| 3Y Cumulative Return | -6% |
| 5Y Cumulative Return | -0.40% |
| 7Y Cumulative Return | 0.00% |
| 10Y Cumulative Return | 0.20% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -71.83 Cr |
| Cash Flow from Operations (TTM) | 141.18 Cr |
| Cash Flow from Financing (TTM) | -67.59 Cr |
| Cash & Equivalents | 46.6 Cr |
| Free Cash Flow (TTM) | 57.79 Cr |
| Free Cash Flow/Share (TTM) | 14.09 |
Balance Sheet | |
|---|---|
| Total Assets | 1.9 kCr |
| Total Liabilities | 1.04 kCr |
| Shareholder Equity | 862.03 Cr |
| Current Assets | 787.07 Cr |
| Current Liabilities | 778.71 Cr |
| Net PPE | 988.5 Cr |
| Inventory | 366.53 Cr |
| Goodwill | 7.5 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.14 |
| Debt/Equity | 0.31 |
| Interest Coverage | 0.61 |
| Interest/Cashflow Ops | 3.73 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 3 |
| Dividend Yield | 0.78% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | -3.4% |
Balance Sheet: Strong Balance Sheet.
Momentum: Stock price has a strong positive momentum. Stock is up 17.3% in last 30 days.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money has been increasing their position in the stock.
Past Returns: Underperforming stock! In past three years, the stock has provided -6% return compared to 10.2% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 0.78% |
| Dividend/Share (TTM) | 3 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 15.77 |
Financial Health | |
|---|---|
| Current Ratio | 1.01 |
| Debt/Equity | 0.31 |
Technical Indicators | |
|---|---|
| RSI (14d) | 60.69 |
| RSI (5d) | 81.83 |
| RSI (21d) | 67.33 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Sell |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Sell |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal | Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Somany Ceramics's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In their Q3 FY 2025-26 earnings call, management highlighted a cautiously optimistic outlook, anticipating continued growth in domestic demand and export levels. They projected an export value close to INR 19,000 to INR 19,500 crores, marking an 8% to 9% increase from the previous year. Sales growth for the company was reported at 6% for the quarter, with expectations of improved performance moving forward.
Key points include:
Management expressed confidence in enhancing operational efficiency and brand positioning, with ongoing efforts to bundle products and improve the overall sales mix. Overall, they appear optimistic about achieving better performance in the upcoming quarters.
Here are the major questions and their detailed answers from the Q&A section of the earnings call transcript:
Question 1: "Can we actually see some light at the end of the tunnel in the domestic market itself because the volume growth still seems to be on a muted side?"
Answer: Yes, we see a light at the end of the tunnel. Recent walk-ins in the market have improved, and our discussions with dealers indicate a positive trend. Customers are increasingly visiting showrooms, reflecting improved sentiment in domestic demand.
Question 2: "Can we also get some flavor on what's really happening with the projects market? How has the demand been for projects for you?"
Answer: Retail sales remain significant, comprising about 77% to 78% of our sales. However, our project business is growing, albeit gradually as approvals and material acquisition take time. We expect this segment to grow to approximately 75% next year.
Question 3: "Could you repeat the debt repayment number? Where would we see this number falling to in FY '27?"
Answer: Our current outside debt stands at INR 231 crores, with approximately INR 9 crores paid this year and around INR 70 crores in FY '27 and '28. We anticipate reducing this to about INR 50 crores by the end of FY '28.
Question 4: "Could you provide an update on the losses from the Max plant and its expected timeline for breakeven?"
Answer: We anticipate reducing losses from the Max plant to below INR 10 crores next year. While breakeven is likely 18 months away, we're confident in our ability to significantly improve the plant's performance.
Question 5: "How is the gas and propane mix currently in your operations?"
Answer: In the North plant, we primarily use natural gas, while the Morbi plant fluctuates between gas and propane based on pricing. Overall, we maintain flexibility to manage costs effectively across our different plants.
Question 6: "What is the state of the advertising spend for this quarter compared to last year?"
Answer: Our advertising expenditure this quarter is approximately 2%, mainly due to the absence of costs related to prior endorsements. Moving forward, we expect ad spend to return to 2.5%, aligned with our usual allocation.
Question 7: "What is your outlook for gross margins going forward, given the price changes in the industry?"
Answer: We need to adjust gross margins based on the cost of power and fuel. While margins have been squeezed, we are focusing on R&D and product mix improvement, which should help recover our EBITDA margins once we stabilize pricing.
Question 8: "With changes in the EU-India FDA, how will this impact Somany Ceramics?"
Answer: The EU deal will take time to materialize; however, the recent reduction of VAT in China will enhance India's export competitiveness. Consequently, a rise in exports could indirectly benefit Somany Ceramics, though our direct exports are only around 1.5% to 2%.
These summaries encapsulate the essence of the inquiries and the management's responses, focusing on clarity and concise information regarding the financial performance and strategic outlook of Somany Ceramics Limited.
Understand Somany Ceramics ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| ABHISHEK SOMANY- TRUSTEE OF SHAKTHI FAMILY TRUST | 23.83% |
| SHREEKANT SOMANY- TRUSTEE OF SRIJAN FAMILY TRUST | 10.25% |
| SHRIVATSA SOMANY - TRUSTEE OF SANRAKSHITH FAMILY TRUST | 10.25% |
| KOTAK SMALL CAP FUND | 6.9% |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA CONSUMPTION FUND - FLEXI CAP FUND AND INDIA VALUE FUND | 4.78% |
| ABHISHEK SOMANY HUF (KARTA: ABHISHEK SOMANY) | 4.52% |
| HSBC SMALL CAP FUND - HSBC VALUE FUND | 4.17% |
| FRANKLIN BUILD INDIA FUND - FRANKLIN INDIA FOCUSED EQUITY FUND | 4.11% |
| ANJANA SOMANY | 2.56% |
| MINAL SOMANY | 1.63% |
| SANJEEV VINODCHANDRA PAREKH | 1.55% |
| ICICI PRUDENTIAL BHARAT CONSUMPTION FUND - ICICI PRUDENTIAL HOUSING OPPORTUNITIES FUND | 1.39% |
| KIRTIVARDHAN FINVEST SERVICES LIMITED | 1.03% |
| AANVI SOMANY | 0.71% |
| ANUSHREE CHOPRA | 0.48% |
| SHRIVATSA SOMANY | 0.28% |
| SHREEKANT SOMANY | 0.28% |
| AMEYA SOMANY | 0.15% |
| ABHISHEK SOMANY | 0.05% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Somany Ceramics against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| KAJARIACER | Kajaria Ceramics | 17.89 kCr | 4.73 kCr | +23.40% | +40.20% | 48.05 | 3.78 | - | - |
| CERA | Cera Sanitaryware | 6.57 kCr | 2.01 kCr | +15.30% | -3.30% | 26.77 | 3.27 | - | - |
| PRSMJOHNSN | PRISM JOHNSON | 6.23 kCr | 7.76 kCr | -1.10% | -5.40% | 31.84 | 0.8 | - | - |
| ASIANTILES | ASIAN GRANITO INDIA | 1.72 kCr | 1.71 kCr | +20.80% | +76.00% | 22.82 | 1.01 | - | - |
| HSIL | Hemant Surgical Industries | 351.91 Cr | - | +104.70% | +416.40% | 113.09 | - | - | - |
Comprehensive comparison against sector averages
SOMANYCERA metrics compared to Consumer
| Category | SOMANYCERA | Consumer |
|---|---|---|
| PE | 26.95 | 50.69 |
| PS | 0.63 | 1.44 |
| Growth | 4.5 % | 11.3 % |
Somany Ceramics Limited engages in the manufacture and sale of ceramic tiles and related products in India. It offers ceramic wall and floor, polished vitrified, and glazed vitrified tiles; sanitaryware, such as toilets, basins, vanity cabinets, cisterns, urinals, and sanitary accessories; bath fittings, including faucets, showers, bath fitting accessories, allied products, and health faucets; smart bathware products comprising sensor urinals, sensor faucets and toilets, and dispensers and sanitizers; water heaters; and adhesives. The company provides its products under the Somany brand name. The company also exports its products. Somany Ceramics Limited was incorporated in 1968 and is headquartered in Noida, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
SOMANYCERA vs Consumer (2021 - 2026)